ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,629.88
0.53%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Organon and Co (OGN) Share Price

OGN Organon and Co

20.79
0.20 (0.97%)
29 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Organon and Co NYSE:OGN New York Stock Exchange Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.20 0.97 20.79 0.00 0.00 21.03 20.515 20.76 2,030,415 23:14:04   
*quotes are delayed by at least 20 minutes
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 6.26B 1.02B 3.9779 5.20 5.32B
 Type  Size  Price  Time  Units 
 20 100 20.79 23:14:04 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore OGN News
11/06/202420:17EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
11/06/202420:16EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
11/06/202420:16EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
06/06/202412:00EDGAR2Form 8-K - Current report
24/05/202418:59BWL’Agence européenne des médicaments (EMA) entérine les dépôts de Henlius et d’Organon pour le candidat biosimilaire HLX14 de Prolia ® et Xgeva ® (denosumab)
24/05/202418:59BWEuropäische Arzneimittel-Agentur (EMA) validiert Einreichungen von Henlius und Organon für den Prolia ® und Xgeva ® (Denosumab) Biosimilar-Kandidaten HLX14
24/05/202416:29BW欧州医薬品庁（EMA）、ヘンリウスとオルガノンによるProlia ® およびXgeva ® （デノスマブ）バイオシミラー候補HLX14を認証
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
27/09/202220:55PBBOrigin Enterprises1
21/10/202120:42PBBOrigin enterprises (food & fertilizers)50
Data Downloads for OGN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Organon and Co Articles